{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:52:04Z","timestamp":1781657524565,"version":"3.54.5"},"reference-count":34,"publisher":"Norwegian Medical Association","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"published-print":{"date-parts":[[2012,1,10]]},"DOI":"10.4045\/tidsskr.11.0539","type":"journal-article","created":{"date-parts":[[2012,1,13]],"date-time":"2012-01-13T07:13:09Z","timestamp":1326438789000},"page":"44-7","source":"Crossref","is-referenced-by-count":2,"title":["Dravets syndrom som \u00e5rsak til epilepsi og utviklingshemning"],"prefix":"10.4045","volume":"132","author":[{"given":"Caroline","family":"Lund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bremer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten I.","family":"Lossius","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaja Kristine","family":"Selmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eylert","family":"Brodtkorb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1851-4857","authenticated-orcid":false,"given":"Karl O.","family":"Nakken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","reference":[{"key":"ref=1","unstructured":"Dravet C. Les epilepsies graves de l\u2019enfant. Vie Med 1978; 8: 543\u2009\u2013\u20098."},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989; 30: 389\u2009\u2013\u200999. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2502382&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1528-1157.1989.tb05316.x","DOI":"10.1111\/j.1528-1157.1989.tb05316.x"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"Oguni H, Hayashi K, Awaya Y et al. Severe myoclonic epilepsy in infants\u2013a review based on the Tokyo Women\u2019s Medical University series of 84 cases. Brain Dev 2001; 23: 736\u2009\u2013\u200948. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11701288&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/S0387-7604(01)00276-5","DOI":"10.1016\/S0387-7604(01)00276-5"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"Claes L, Del-Favero J, Ceulemans B et al. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J\u00a0Hum Genet 2001; 68: 1327\u2009\u2013\u200932. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11359211&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1086\/320609","DOI":"10.1086\/320609"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"Harkin LA, McMahon JM, Iona X et al. The spectrum of SCN1A-related infantile epileptic encephalopathies. Brain 2007; 130: 843\u2009\u2013\u200952. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17347258&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1093\/brain\/awm002","DOI":"10.1093\/brain\/awm002"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Marini C, Scheffer IE, Nabbout R et al. The genetics of Dravet syndrome. Epilepsia 2011; 52 (suppl\u00a02): 24\u2009\u2013\u20099. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=21463275&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1528-1167.2011.02997.x","DOI":"10.1111\/j.1528-1167.2011.02997.x"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Morse RP. Dravet syndrome: inroads into understanding epileptic encephalopathies. J Pediatr 2011; 158: 354\u2009\u2013\u20099. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=21163495&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/j.jpeds.2010.10.035","DOI":"10.1016\/j.jpeds.2010.10.035"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"Hurst DL. Epidemiology of severe myoclonic epilepsy of infancy. Epilepsia 1990; 31: 397\u2009\u2013\u2009400. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1695145&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1528-1157.1990.tb05494.x","DOI":"10.1111\/j.1528-1157.1990.tb05494.x"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"Yakoub M, Dulac O, Jambaqu\u00e9 I et al. Early diagnosis of severe myoclonic epilepsy in infancy. Brain Dev 1992; 14: 299\u2009\u2013\u2009303. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1456383&dopt=Abstract","DOI":"10.1016\/S0387-7604(12)80147-1"},{"key":"ref=10","unstructured":"Dravet C, Daquin G, Battaglia D. Severe myoclonic epilepsy of infancy (Dravet syndrome). I: Nikanorova M, Genton P, Sabers A, red. Long-term evolution of epileptic encephalopathies. Surrey: John Libbey; 2009: 29\u2009\u2013\u200938."},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"Sakauchi M, Oguni H, Kato I et al. Mortality in Dravet syndrome: search for risk factors in Japanese patients. Epilepsia 2011; 52 (suppl 2): 50\u2009\u2013\u20094. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=21463280&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1528-1167.2011.03002.x","DOI":"10.1111\/j.1528-1167.2011.03002.x"},{"key":"ref=12","unstructured":"Dravet C, Bureau M, Guerrini R et al. Severe myoclonic epilepsy in infants. I: Roger J, Bureau M, Dravet C, red. Epileptic syndromes in infancy, childhood and adolescence. London: John Libbey. 1992: 29\u2009\u2013\u200938."},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"Akiyama M, Kobayashi K, Yoshinaga H et al. A\u00a0long-term follow-up study of Dravet syndrome up to adulthood. Epilepsia 2010; 51: 1043\u2009\u2013\u200952. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20041943&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1528-1167.2009.02466.x","DOI":"10.1111\/j.1528-1167.2009.02466.x"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"Genton P, Velizarova R, Dravet C. Dravet syndrome: the long-term outcome. Epilepsia 2011; 52\u00a0(suppl 2): 44\u2009\u2013\u20099. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=21463279&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1528-1167.2011.03001.x","DOI":"10.1111\/j.1528-1167.2011.03001.x"},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"Dravet C. The core Dravet syndrome phenotype. Epilepsia 2011; 52 (suppl 2): 3\u2009\u2013\u20099. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=21463272&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1528-1167.2011.02994.x","DOI":"10.1111\/j.1528-1167.2011.02994.x"},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"Berkovic SF, Harkin L, McMahon JM et al. De-novo mutations of the sodium channel gene SCN1A in alleged vaccine encephalopathy: a retrospective study. Lancet Neurol 2006; 5: 488\u2009\u2013\u200992. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16713920&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/S1474-4422(06)70446-X","DOI":"10.1016\/S1474-4422(06)70446-X"},{"key":"ref=17","doi-asserted-by":"crossref","unstructured":"Wolff M, Cass\u00e9-Perrot C, Dravet C. Severe myoclonic epilepsy of infants (Dravet syndrome): natural history and neuropsychological findings. Epilepsia 2006; 47 (suppl 2): 45\u2009\u2013\u20098. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17105460&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1528-1167.2006.00688.x","DOI":"10.1111\/j.1528-1167.2006.00688.x"},{"key":"ref=18","doi-asserted-by":"crossref","unstructured":"Ragona F. Cognitive development in children with Dravet syndrome. Epilepsia 2011; 52 (suppl 2): 39\u2009\u2013\u200943. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=21463278&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1528-1167.2011.03000.x","DOI":"10.1111\/j.1528-1167.2011.03000.x"},{"key":"ref=19","doi-asserted-by":"crossref","unstructured":"Jansen FE, Sadleir LG, Harkin LA et al. Severe myoclonic epilepsy of infancy (Dravet syndrome): recognition and diagnosis in adults. Neurology 2006; 67: 2224\u2009\u2013\u20096. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17190949&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1212\/01.wnl.0000249312.73155.7d","DOI":"10.1212\/01.wnl.0000249312.73155.7d"},{"key":"ref=20","doi-asserted-by":"crossref","unstructured":"Verbeek NE, van Kempen M, Gunning WB et al. Adults with a history of possible Dravet syndrome: An illustration of the importance of analysis of the SCN1A gene. Epilepsia 2011; 52: e23\u2009\u2013\u20095. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=21542839&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1528-1167.2011.02982.x","DOI":"10.1111\/j.1528-1167.2011.02982.x"},{"key":"ref=21","doi-asserted-by":"crossref","unstructured":"Scheffer IE, Berkovic SF. Generalized epilepsy with\u00a0febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes. Brain 1997; 120: 479\u2009\u2013\u200990. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9126059&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1093\/brain\/120.3.479","DOI":"10.1093\/brain\/120.3.479"},{"key":"ref=22","doi-asserted-by":"crossref","unstructured":"Depienne C, Bouteiller D, Keren B et al. Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females. PLoS Genet 2009; 5: e1000381. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19214208&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1371\/journal.pgen.1000381","DOI":"10.1371\/journal.pgen.1000381"},{"key":"ref=23","doi-asserted-by":"crossref","unstructured":"Chiron C. Current therapeutic procedures in Dravet syndrome. Dev Med Child Neurol 2011; 53\u00a0(suppl 2): 16\u2009\u2013\u20098. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=21504427&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1469-8749.2011.03967.x","DOI":"10.1111\/j.1469-8749.2011.03967.x"},{"key":"ref=24","doi-asserted-by":"crossref","unstructured":"Coppola G, Capovilla G, Montagnini A et al. Topiramate as add-on drug in severe myoclonic epilepsy in infancy: an Italian multicenter open trial. Epilepsy Res 2002; 49: 45\u2009\u2013\u20098. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11948006&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/S0920-1211(02)00010-4","DOI":"10.1016\/S0920-1211(02)00010-4"},{"key":"ref=25","doi-asserted-by":"crossref","unstructured":"Striano P, Coppola A, Pezzella M et al. An open-label trial of levetiracetam in severe myoclonic epilepsy of infancy. Neurology 2007; 69: 250\u2009\u2013\u20094. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17636062&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1212\/01.wnl.0000265222.24102.db","DOI":"10.1212\/01.wnl.0000265222.24102.db"},{"key":"ref=26","doi-asserted-by":"crossref","unstructured":"Chiron C, Marchand MC, Tran A et al. Stiripentol in\u00a0severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group. Lancet 2000; 356: 1638\u2009\u2013\u200942. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11089822&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/S0140-6736(00)03157-3","DOI":"10.1016\/S0140-6736(00)03157-3"},{"key":"ref=27","doi-asserted-by":"crossref","unstructured":"Thanh TN, Chiron C, Dellatolas G et al. [Long-term efficacy and tolerance of stiripentaol in severe myoclonic epilepsy of infancy (Dravet\u2019s syndrome]. Arch Pediatr 2002; 9: 1120\u2009\u2013\u20097. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12503502&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/S0929-693X(02)00090-8","DOI":"10.1016\/S0929-693X(02)00090-8"},{"key":"ref=28","doi-asserted-by":"crossref","unstructured":"Inoue Y, Ohtsuka Y, Oguni H et al. Stiripentol open study in Japanese patients with Dravet syndrome. Epilepsia 2009; 50: 2362\u2009\u2013\u20098. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19552653&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1528-1167.2009.02179.x","DOI":"10.1111\/j.1528-1167.2009.02179.x"},{"key":"ref=29","doi-asserted-by":"crossref","unstructured":"Guerrini R, Dravet C, Genton P et al. Lamotrigine and seizure aggravation in severe myoclonic epilepsy. Epilepsia 1998; 39: 508\u2009\u2013\u200912. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9596203&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1528-1157.1998.tb01413.x","DOI":"10.1111\/j.1528-1157.1998.tb01413.x"},{"key":"ref=30","doi-asserted-by":"crossref","unstructured":"Horn CS, Ater SB, Hurst DL. Carbamazepine-exacerbated epilepsy in children and adolescents. Pediatr Neurol 1986; 2: 340\u2009\u2013\u20095. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=3508708&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/0887-8994(86)90074-3","DOI":"10.1016\/0887-8994(86)90074-3"},{"key":"ref=31","doi-asserted-by":"crossref","unstructured":"Yu FH, Mantegazza M, Westenbroek RE et al. Reduced sodium current in GABA-ergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat Neurosci 2006; 9: 1142\u2009\u2013\u20099. Crossref: http:\/\/dx.doi.org\/10.1038\/nn1754","DOI":"10.1038\/nn1754"},{"key":"ref=32","doi-asserted-by":"crossref","unstructured":"Caraballo RH, Cers\u00f3simo RO, Sakr D et al. Ketogenic diet in patients with Dravet syndrome. Epilepsia 2005; 46: 1539\u2009\u2013\u200944. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16146451&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1528-1167.2005.05705.x","DOI":"10.1111\/j.1528-1167.2005.05705.x"},{"key":"ref=33","doi-asserted-by":"crossref","unstructured":"Zamponi N, Passamonti C, Cappanera S et al. Clinical course of young patients with Dravet syndrome after vagal nerve stimulation. Eur J\u00a0Paediatr Neurol 2011; 15: 8\u2009\u2013\u200914. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20971664&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/j.ejpn.2010.09.003","DOI":"10.1016\/j.ejpn.2010.09.003"},{"key":"ref=34","doi-asserted-by":"crossref","unstructured":"Ceulemans B. Overall management of patients with Dravet syndrome. Dev Med Child Neurol 2011; 53 (suppl 2): 19\u2009\u2013\u200923. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=21504428&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1469-8749.2011.03968.x","DOI":"10.1111\/j.1469-8749.2011.03968.x"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":[],"language":"no","deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:59:20Z","timestamp":1781654360000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2012\/01\/oversiktsartikkel\/dravets-syndrom-som-arsak-til-epilepsi-og-utviklingshemning"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,10]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1,10]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.11.0539","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,10]]}}}